U.S. flag

An official website of the United States government

NM_000287.4(PEX6):c.1992G>C (p.Glu664Asp) AND Peroxisome biogenesis disorder 4A (Zellweger)

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Aug 7, 2024
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004697090.1

Allele description [Variation Report for NM_000287.4(PEX6):c.1992G>C (p.Glu664Asp)]

NM_000287.4(PEX6):c.1992G>C (p.Glu664Asp)

Gene:
PEX6:peroxisomal biogenesis factor 6 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
6p21.1
Genomic location:
Preferred name:
NM_000287.4(PEX6):c.1992G>C (p.Glu664Asp)
HGVS:
  • NC_000006.12:g.42966627C>G
  • NG_008370.1:g.17617G>C
  • NM_000287.4:c.1992G>CMANE SELECT
  • NM_001316313.2:c.1728G>C
  • NP_000278.3:p.Glu664Asp
  • NP_001303242.1:p.Glu576Asp
  • NC_000006.11:g.42934365C>G
  • NC_000006.11:g.42934365C>G
  • NM_000287.3:c.1992G>C
  • NR_133009.2:n.2023G>C
Protein change:
E576D
Links:
dbSNP: rs267608230
NCBI 1000 Genomes Browser:
rs267608230
Molecular consequence:
  • NM_000287.4:c.1992G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001316313.2:c.1728G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NR_133009.2:n.2023G>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
Observations:
1

Condition(s)

Name:
Peroxisome biogenesis disorder 4A (Zellweger) (PBD4A)
Synonyms:
Zellweger syndrome spectrum (PEX6-related)
Identifiers:
MONDO: MONDO:0013930; MedGen: C3553936; Orphanet: 912; OMIM: 614862

Recent activity

  • Hippocampus
    Hippocampus
    A curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subi...<br/>Year introduced: 2015(1966)
    MeSH
  • Blood-Brain Barrier
    Blood-Brain Barrier
    Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the...<br/>Year introduced: 1966
    MeSH

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV005184165Next Generation Genetic Polyclinic
no assertion criteria provided
Likely pathogenic
(Aug 7, 2024)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
persiangermlineyes1not providednot providednot providednot providedclinical testing

Details of each submission

From Next Generation Genetic Polyclinic, SCV005184165.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1persian1not providednot providedclinical testingnot provided

Description

The NM_000287.4 c.1992G>C variant in the PEX6 gene is a missense mutation that results in the substitution of glycine with arginine at codon 664 (p.Gly664Arg). This variant has been identified as mutated homozygous in the proband and heterozygous in her parent using Sanger sequencing method. This variant has been reported in individuals with peroxisomal biogenesis disorders, suggesting a potential pathogenic role. Using predictive tools such as SIFT and PolyPhen, this variant is assessed as likely deleterious. SIFT suggests that it may disrupt protein function, while PolyPhen indicates that it could be damaging to the protein's structure. In summary, this variant aligns with criteria set forth by the ClinGen PEX6 VCEP, indicating it may contribute to the patient's clinical presentation and warrant further investigation for potential implications in diagnosis and management. Functional studies are needed to elucidate the impact of this variant on protein function. Further evidence, including co-segregation analysis and population frequency data, should be considered to assess its clinical significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Sep 29, 2024